9837 related articles for article (PubMed ID: 18695716)
21. Synthesis and antitumor activity of peptide-paclitaxel conjugates.
Papas S; Akoumianaki T; Kalogiros C; Hadjiarapoglou L; Theodoropoulos PA; Tsikaris V
J Pept Sci; 2007 Oct; 13(10):662-71. PubMed ID: 17787026
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic simplified tubulysin analogues.
Raghavan B; Balasubramanian R; Steele JC; Sackett DL; Fecik RA
J Med Chem; 2008 Mar; 51(6):1530-3. PubMed ID: 18314944
[TBL] [Abstract][Full Text] [Related]
23. Progress toward the total synthesis of lucentamycin A: total synthesis and biological evaluation of 8-epi-lucentamycin A.
Daniels RN; Melancon BJ; Wang EA; Crews BC; Marnett LJ; Sulikowski GA; Lindsley CW
J Org Chem; 2009 Nov; 74(22):8852-5. PubMed ID: 19908916
[TBL] [Abstract][Full Text] [Related]
24. The effect of conjugation on antitumor activity of vindoline derivatives with octaarginine, a cell-penetrating peptide.
Bánóczi Z; Keglevich A; Szabó I; Ranđelović I; Hegedüs Z; Regenbach FL; Keglevich P; Lengyel Z; Gorka-Kereskényi Á; Dubrovay Z; Háda V; Szigetvári Á; Szántay C; Hazai L; Tóvári J; Hudecz F
J Pept Sci; 2018 Oct; 24(10):e3118. PubMed ID: 30084214
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors.
Terrillon S; Cheng LL; Stoev S; Mouillac B; Barberis C; Manning M; Durroux T
J Med Chem; 2002 Jun; 45(12):2579-88. PubMed ID: 12036367
[TBL] [Abstract][Full Text] [Related]
27. One-step synthesis of peptide-programmed QDs as ready-to-use nanoprobes.
Jia J; Zhang P; Gao D; Sheng Z; Hu D; Gong P; Wu C; Chen J; Cai L
Chem Commun (Camb); 2013 May; 49(40):4492-4. PubMed ID: 23575527
[TBL] [Abstract][Full Text] [Related]
28. New analogues of laminin active fragment YIGSR: synthesis and biological activity in vitro and in vivo.
Witkowska E; Oriowska A; Izdebski J; Salwa J; Wietrzyk J; Opolski A
J Pept Sci; 2004 May; 10(5):285-90. PubMed ID: 15160840
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of selective fluorescent ligands for the neurokinin NK2 receptor.
Bradshaw CG; Ceszkowski K; Turcatti G; Beresford IJ; Chollet A
J Med Chem; 1994 Jun; 37(13):1991-5. PubMed ID: 8027981
[TBL] [Abstract][Full Text] [Related]
30. Syntheses of amamistatin fragments and determination of their HDAC and antitumor activity.
Fennell KA; Miller MJ
Org Lett; 2007 Apr; 9(9):1683-5. PubMed ID: 17397173
[TBL] [Abstract][Full Text] [Related]
31. Development of new fluorescent xanthines as kinase inhibitors.
Kim D; Jun H; Lee H; Hong SS; Hong S
Org Lett; 2010 Mar; 12(6):1212-5. PubMed ID: 20184370
[TBL] [Abstract][Full Text] [Related]
32. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitumor activity of novel dolastatin 10 analogs.
Miyazaki K; Kobayashi M; Natsume T; Gondo M; Mikami T; Sakakibara K; Tsukagoshi S
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1706-18. PubMed ID: 8536345
[TBL] [Abstract][Full Text] [Related]
34. A new endogenous differentiating factor (myelopeptide-4) for myeloid cells.
Strelkov LA; Mikhailova AA; Fonina LA; Petrov RV
FEBS Lett; 2000 Mar; 470(3):281-4. PubMed ID: 10745082
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of novel fluorogenic substrates of coagulation factor XIII-A.
Hardes K; Zouhir Hammamy M; Steinmetzer T
Anal Biochem; 2013 Nov; 442(2):223-30. PubMed ID: 23933241
[TBL] [Abstract][Full Text] [Related]
36. Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides).
Mikhailova A; Fonina L; Kirilina E; Gur'yanov S; Efremov M; Petrov R
Regul Pept; 2003 Jul; 114(2-3):183-7. PubMed ID: 12832108
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties.
Sun J; Zhang S; Yu C; Hou G; Zhang X; Li K; Zhao F
Chem Biol Drug Des; 2014 Apr; 83(4):392-400. PubMed ID: 24148151
[TBL] [Abstract][Full Text] [Related]
38. Structure and biological activities of a pectic polysaccharide from Mosla chinensis Maxim. cv. Jiangxiangru.
Li JE; Cui SW; Nie SP; Xie MY
Carbohydr Polym; 2014 May; 105():276-84. PubMed ID: 24708981
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iijima M; Iinuma H; Ikeda D
Biosci Biotechnol Biochem; 2005 Sep; 69(9):1733-42. PubMed ID: 16195592
[TBL] [Abstract][Full Text] [Related]
40. Aromatic oligopeptides with chlorambucil moiety--synthesis and biological evaluation.
Bartulewicz D
Acta Pol Pharm; 2005; 62(6):451-5. PubMed ID: 16583984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
